Diagnosis and Complication Risk Assessment of Pancreatic Diabetes within Normal Value Ranges of Leuc
- Summary
- This method use rapid or Automatic test device for procalcitonin blood levels.
- Technology Benefits
- This patent can use for daily complication risk Assessment of all diabetic patients and save lifes, suffering from the diabetic complications at all around the world. it is more important method than Hemoglobin A1c. Because all diabetic complications can monitorizing using one marker (procalcitonin) in 24 hours period. New technology of insulin pump system or traditional diabetes mellitus therapy need this invention for proper diabetic complication (retinopathy, nephropathy,neuropathy) treatment
- Application No.
- EP20120154587
- Coverage Areas
- EPO designated contracting states
- Goods and Services
- License agreement
- Patent Information
- patent application
- Country/Region
- Turkiye
For more information, please click Here
